Vitamin D and the central nervous system

Pharmacological Reports

Volumn 65, Issue 2, 2013, Pages 271-278

  Wrzosek, Malgorzata ^a   Lukaszkiewicz, Jacek ^a   Wrzosek, Michal ^a   Jakubczyk, Andrzej ^a   Matsumoto, Halina ^a   Piatkiewicz, Pawel ^a   Radziwon Zaleska, Maria ^a   Wojnar, Marcin ^a,b   Nowicka, Grazyna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Central nervous system; Vitamin D

Indexed keywords

ANTICONVULSIVE AGENT; CALCITRIOL; COLECALCIFEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTROPHIN; NITRIC OXIDE SYNTHASE; OXYGENASE; PROGESTERONE; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ALZHEIMER DISEASE; BONE METABOLISM; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; EPILEPSY; GENETIC POLYMORPHISM; HUMAN; HYDROXYLATION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PHOTOCHEMISTRY; PROTEIN EXPRESSION; REVIEW; TISSUE DISTRIBUTION; TRAUMATIC BRAIN INJURY; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

EID: 84879354705     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71003-X     Document Type: Review

References (70)

1. Bartels LE, Jørgensen SP, Agnholt J, Kelsen J, Hvas CL, Dahlerup JF: 1,25-Dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease. Int Immunopharmacol, 2007, 7, 1755-1764.
2. Borowicz KK, Morawska M, Furmanek-Karwowska K, Luszczki JJ, Czuczwar SJ: Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. Eur J Pharmacol, 2007, 573, 111-115.
3. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM: Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci, 2001, 21, 98-108.
4. Brown J, Bianco JI, McGrath JJ, Eyles DW: 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett, 2003, 343, 139-143.
5. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P et al.: 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology, 2010, 74, 18-26.
6. Chaudhuri A: Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses, 2005, 64, 608-618.
7. Correale J, Ysrraelit MC, Gaitán MI: Immunomodulatory effects of vitamin D in multiple sclerosis. Brain, 2009, 132, 1146-1160.
8. De Luca HF: Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr, 2004, 80, 1689-1696.
9. de Viragh PA, Haglid KG, Celio MR: Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci USA, 1989, 86, 3887-3890.
10. Diesel B, Radermacher J, Bureik M, Bernhardt R, Seifert M, Reichrath J, Fischer U, Meese E: Vitamin D3 metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin Cancer Res, 2005, 11, 5370-5380.
11. Dong XX, Wang Y, Qin ZH: Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin, 2009, 30, 379-387.
12. Dursun E, Gezen-Ak D, Yilmazer S: A novel perspective for Alzheimer's disease: Vitamin D receptor suppression by amyloid-b and preventing the amyloid-b induced alterations by vitamin D in cortical neurons. J Alzheimers Dis, 2011, 23, 207-219.
13. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol, 2005, 289, F8-28.
14. Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V: Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol, 2008, 65, 1348-1352.
15. Eyles D, Burne T, McGrath J: Vitamin D in fetal brain development. Semin Cell Dev Biol, 2011, 22, 629-636.
16. Eyles DW, Burne TH, McGrath JJ: Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol, 2013, 34, 47-64.
17. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ: Distribution of the vitamin D receptor and 1a-hydroxylase in human brain. J Chem Neuroanat, 2005, 29, 21-30.
18. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M: Multiple actions of steroid hormones -A focus on rapid, nongenomic effects. Pharmacol Rev, 2000, 52, 513-556.
19. Farid K, Volpe-Gillot L, Petras S, Plou C, Caillat-Vigneron N, Blacher J: Correlation between serum 25-hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia. Nucl Med Commun, 2012, 33, 1048-1052.
20. Fernandes de Abreu DA, Eyles D, Féron F: Vitamin D, a neuro-immunomodulator: implications for neurodegen-erative and autoimmune diseases. Psychoneuroendocrinology, 2009, 34, 265-277.
21. Fernandes de Abreu DA, Nivet E, Baril N, Khrestchatisky M, Roman F, Féron F: Developmental vitamin D deficiency alters learning in C57Bl/6J mice. Behav Brain Res, 2010, 208, 603-608.
22. Féron F, Burne TH, Brown J, Smith E, McGrath JJ, Mackay-Sim A, Eyles DW: Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull, 2005, 65, 141-148.
23. Ganji V, Milone C, Cody MM, McCarty F, Wang YT: Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med, 2010, 11, 3-29.
24. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D: New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab, 2002, 13, 100-105.
25. Gruszczynska-Biegala J, Pomorski P, Wisniewska MB, Kuznicki J: Differential roles for STIM1 and STIM2 in store-operated calcium entry in rat neurons. PLoS One, 2011, 6, e19285.
26. Handoko HY, Nancarrow DJ, Mowry BJ, McGrath JJ: Polymorphisms in the vitamin D receptor and their associations with risk of schizophrenia and selected anthropometric measures. Am J Hum Biol, 2006, 18, 415-417.
27. Harms LR, Burne TH, Eyles DW, McGrath JJ: Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab, 2011, 25, 657-669.
28. Harms LR, Eyles DW, McGrath JJ, Mackay-Sim A, Burne TH: Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice. Behav Brain Res, 2008, 187, 343-350.
29. Holick MF: The vitamin D epidemic and its health consequences. J Nutr, 2005, 135, 2739S-2748S.
30. Holló A, Clemens Z, Kamondi A, Lakatos P, Szûcs A: Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav, 2012, 24, 131-133.
31. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW: Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry, 2008, 65, 508-512.
32. Hua F, Reiss JI, Tang H, Wang J, Fowler X, Sayeed I, Stein DG: Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury. Horm Behav, 2012, 61, 642-651.
33. Huang J, Xie ZF: Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-Analysis of case-control studies. J Neurol Sci, 2012, 313, 79-85.
34. Huh SY, Gordon CM: Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord, 2008, 9, 161-170.
35. Jamilian H, Bagherzadeh K, Nazeri Z, Hassanijirdehi M: Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression. Int J Psychiatry Clin Pract, 2013, 17, 30-34.
36. Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P: Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci Lett, 2006, 394, 69-73.
37. Kesby JP, Burne TH, McGrath JJ, Eyles DW: Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: an animal model of schizophrenia. Biol Psychiatry, 2006, 60, 591-596.
38. Khanal RC, Peters TM, Smith NM, Nemere I: Membrane receptor-initiated signaling in 1,25(OH)2D3-stimulated calcium uptake in intestinal epithelial cells. J Cell Biochem, 2008, 105, 1109-1116.
39. Kimball SM, Ursell MR, O'Connor P, Vieth R: Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr, 2007, 86, 645-651.
40. Kiviluoto S, Decuypere JP, De Smedt H, Missiaen L, Parys JB, Bultynck G: STIM1 as a key regulator for Ca2+ homeostasis in skeletal-muscle development and function. Skelet Muscle, 2011, 4, 1-16.
41. Lefebvre d'Hellencourt C, Montero-Menei CN, Bernard R, Couez D : Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J Neurosci Res, 2003, 71, 575-582.
42. Mackay-Sim A, Féron F, Eyles D, Burne T, McGrath J: Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol, 2004, 59, 351-380.
43. May HT, Bair TL, Lappé DL, Anderson JL, Horne BD, Carlquist JF, Muhlestein JB: Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J, 2010, 159, 1037-1043.
44. McGrath J: Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res, 1999, 40, 173-177.
45. McGrath J, Eyles D, Mowry B, Yolken R, Buka S: Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr Res, 2003, 63, 73-78.
46. McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, Burne TH, Norgaard-Pedersen B et al.: Neonatal vitamin D status and risk oof schizophrenia: a population-based case-control study. Arch Gen Psychiatry, 2010, 67, 889-894.
47. McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Järvelin MR, Chant D, Isohanni M: Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res, 2004, 67, 237-245.
48. Mowry EM. Vitamin D: evidence for its role as a prognostic factor in multiple sclerosis. J Neurol Sci, 2011, 311, 19-22.
49. Nemere I, Garbi N, Hämmerling GJ, Khanal RC: Intestinal cell calcium uptake and the targeted knockout of the 1,25D3-MARRS (membrane-Associated, rapid response steroid-binding) receptor/PDIA3/Erp57. J Biol Chem, 2010, 285, 31859-31866.
50. Norman AW: From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Review. Am J Clin Nutr, 2008, 88, 491S-499S.
51. Pannu R, Singh I: Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem Int, 2006, 49, 170-182.
52. Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK: Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res, 1996, 36, 193-196.
53. Reichrath S, Müller CS, Gleissner B, Pfreundschuh M, Vogt T, Reichrath J: Notch-And vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines. J Steroid Biochem Mol Biol, 2010, 121, 420-424.
54. Robin E, Derichard A, Vallet B, Hassoun SM, Neviere R: Nitric oxide scavenging modulates mitochondrial dysfunction induced by hypoxia/reoxygenation. Pharmacol Rep, 2011, 63, 1189-1194.
55. Rovner AJ, O'Brien KO: Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch Pediatr Adolesc Med, 2008, 162, 513-519.
56. Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R: 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J Neurosci Res, 2009, 87, 723-732.
57. Schuster I: Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta, 2011, 1814, 186-199.
58. Shinpo K, Kikuchi S, Sasaki H, Moriwaka F, Tashiro K: Effect of 1,25-dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4- phenylpyridine. J Neurosci Res, 2000, 62, 374-382.
59. Smolders J, Damoiseaux J, Menheere P, Hupperts R: Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol, 2008, 194, 7-17.
60. Sonnenberg J, Luine VN, Krey LC, Christakos S: 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology, 1986, 118, 1433-1439.
61. Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A: Vitamin D, nervous system and aging. Psychoneuroendocrinology, 2009, 34, Suppl 1, 278-286.
62. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP: Genetics and biology of vitamin D receptor polymorphisms. Gene, 2004, 338, 143-56.
63. Valdivielso JM, Fernandez E: Vitamin D receptor polymorphisms and diseases. Clin Chim Acta, 2006, 371, 1-12.
64. Van der Schueren BJ, Verstuyf A, Mathieu C: Straight from D-Heart: vitamin D status and cardiovascular disease. Curr Opin Lipidol, 2012, 23, 17-23.
65. Vazquez G, de Boland AR, Boland RL: 1a,25-Dihydroxy-vitamin-D3-induced store-operated Ca2+ influx in skeletal muscle cells. Modulation by phospholipase C, protein kinase C, and tyrosine kinases. J Biol Chem, 1998, 273, 33954-33960.
66. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V et al.: Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol, 2005, 19, 2685-2695.
67. Waschbisch A, Wenny I, Tallner A, Schwab S, Pfeifer K, Mäurer M: Physical activity in multiple sclerosis: a comparative study of vitamin D, brain-derived neurotrophic factor and regulatory T cell populations. Eur Neurol, 2012, 68, 122-128.
68. Webb AR: Who, what, where and when -influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol, 2006, 92, 17-25.
69. Yagishita T, Kushida A, Tamura H: Vitamin D3 enhances all-trans retinoic acid (ATRA)-mediated neurosteroid biosynthesis in human glioma GI-1 cells. J Biochem 2012, 152, 285-292.
70. Zanatta L, Goulart PB, Gonçalves R, Pierozan P, Winkelmann-Duarte EC, Woehl VM, Pessoa-Pureur R et al.: 1a,25-Dihydroxyvitamin D3 mechanism of action: Modulation of L-type calcium channels leading to calcium uptake and intermediate filament phosphorylation in cerebral cortex of young rats. Biochim Biophys Acta, 2012, 1823, 1708-1719.